116 related articles for article (PubMed ID: 8116075)
1. Ductal adenocarcinoma of the pancreas: clinicopathologic features and survival.
Sperti C; Bonadimani B; Pasquali C; Piccoli A; Cappellazzo F; Rugge M; Pedrazzoli S
Tumori; 1993 Oct; 79(5):325-30. PubMed ID: 8116075
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
Conlon KC; Klimstra DS; Brennan MF
Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in the operative treatment of ductal pancreatic carcinoma.
Gebhardt C; Meyer W; Reichel M; Wünsch PH
Langenbecks Arch Surg; 2000 Jan; 385(1):14-20. PubMed ID: 10664114
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
Shahrudin MD
Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
[TBL] [Abstract][Full Text] [Related]
5. Ductal adenocarcinoma of the pancreas. Histopathological features and prognosis.
Tannapfel A; Wittekind C; Hünefeld G
Int J Pancreatol; 1992 Oct; 12(2):145-52. PubMed ID: 1460329
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
Nitecki SS; Sarr MG; Colby TV; van Heerden JA
Ann Surg; 1995 Jan; 221(1):59-66. PubMed ID: 7826162
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
[TBL] [Abstract][Full Text] [Related]
8. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
[TBL] [Abstract][Full Text] [Related]
9. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.
Fortner JG; Klimstra DS; Senie RT; Maclean BJ
Ann Surg; 1996 Feb; 223(2):147-53. PubMed ID: 8597508
[TBL] [Abstract][Full Text] [Related]
10. The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.
Lüttges J; Vogel I; Menke M; Henne-Bruns D; Kremer B; Klöppel G
Virchows Arch; 1998 Sep; 433(3):237-42. PubMed ID: 9769127
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
12. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
[TBL] [Abstract][Full Text] [Related]
13. Survival after resection for ductal adenocarcinoma of the pancreas.
Sperti C; Pasquali C; Piccoli A; Pedrazzoli S
Br J Surg; 1996 May; 83(5):625-31. PubMed ID: 8689203
[TBL] [Abstract][Full Text] [Related]
14. Recurrence after resection for ductal adenocarcinoma of the pancreas.
Sperti C; Pasquali C; Piccoli A; Pedrazzoli S
World J Surg; 1997 Feb; 21(2):195-200. PubMed ID: 8995078
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
[TBL] [Abstract][Full Text] [Related]
16. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M
Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
[TBL] [Abstract][Full Text] [Related]
18. The mode of lymphatic and local spread of pancreatic carcinomas less than 4.0 cm in size.
Ohta T; Nagakawa T; Ueno K; Kayahara M; Mori K; Kobayashi H; Takeda T; Miyazaki I
Int Surg; 1993; 78(3):208-12. PubMed ID: 8276542
[TBL] [Abstract][Full Text] [Related]
19. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive histological evaluation with clinical analysis of venous invasion in pancreatic ductal adenocarcinoma: From histology to clinical implications.
Lee SJ; Sung YN; Kim SJ; Shin S; Cho H; Hruban RH; Hong SM
Pancreatology; 2020 Oct; 20(7):1486-1494. PubMed ID: 32948429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
